UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
QUARTERLY REPORT ON FORM 10-Q
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2004 |
COMMISSION FILE NUMBER 0-21013
XYBERNAUT CORPORATION
(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)
DELAWARE (STATE OR OTHER JURISDICTION OF INCORPORATION) |
54-1799851 (I.R.S. EMPLOYER IDENTIFICATION NO.) |
12701 FAIR LAKES CIRCLE, FAIRFAX, VA 22033
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES WITH ZIP CODE)
(703) 631-6925
(REGISTRANTS TELEPHONE NUMBER, INCLUDING AREA CODE)
Check whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [x] No [ ]
Indicate by check mark whether the registrant is an accelerated filer (as defined in Exchange Act Rule 12b-2). Yes [x] No [ ]
The number of shares outstanding of the registrants Common Stock, $0.01 par value per share, as of November 4, 2004 was 179,202,035.
XYBERNAUT CORPORATION
QUARTERLY REPORT ON FORM 10-Q
PAGE | ||||
COVER PAGE |
1 | |||
INDEX |
2 | |||
PART I FINANCIAL INFORMATION |
||||
Item 1 - Financial Statements |
||||
Condensed Consolidated Balance Sheets |
3 | |||
Condensed Consolidated Statements of Operations |
4 | |||
Condensed Consolidated Statements of Cash Flows |
5 | |||
Notes to Condensed Consolidated Financial Statements |
6 | |||
Item 2 - Managements Discussion and Analysis of Financial Condition and Results of Operations |
13 | |||
Item 3 - Quantitative and Qualitative Disclosures about Market Risk |
21 | |||
Item 4 - Controls and Procedures |
22 | |||
PART II OTHER INFORMATION |
||||
Item 1- Legal Proceedings |
23 | |||
Item 2 - Changes in Securities, Use of Proceeds and Issuer Purchases of Equity Securities |
23 | |||
Item 6 - Exhibits |
23 | |||
SIGNATURES |
24 |
2
PART I FINANCIAL INFORMATION
Item 1 Financial Statements
XYBERNAUT CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(UNAUDITED) | ||||||||
September 30, | December 31, | |||||||
2004 |
2003 |
|||||||
ASSETS |
||||||||
Current assets: |
||||||||
Cash and cash equivalents |
$ | 6,007,537 | $ | 9,524,541 | ||||
Restricted cash |
706,750 | 1,257,554 | ||||||
Accounts receivable, net of allowances of $533,436 and $557,679 |
3,203,146 | 4,883,899 | ||||||
Inventory, net of reserves of $3,272,716 and $3,272,716 |
2,637,345 | 2,131,436 | ||||||
Prepaid and other current assets |
2,409,136 | 984,425 | ||||||
Total current assets |
14,963,914 | 18,781,855 | ||||||
Long-term assets: |
||||||||
Property, equipment and demonstration units, net |
650,721 | 382,792 | ||||||
Patent costs, net of accumulated amortization of $2,303,101
and $1,963,971 |
914,798 | 945,126 | ||||||
Other |
540,080 | 710,294 | ||||||
Total long-term assets |
2,105,599 | 2,038,212 | ||||||
Total assets |
$ | 17,069,513 | $ | 20,820,067 | ||||
LIABILITIES AND STOCKHOLDERS EQUITY |
||||||||
Liabilities: |
||||||||
Current liabilities: |
||||||||
Accounts payable |
$ | 2,469,693 | $ | 3,068,374 | ||||
Accrued expenses and other |
1,513,905 | 1,283,200 | ||||||
Deferred revenue |
230,379 | 332,884 | ||||||
Total current liabilities |
4,213,977 | 4,684,458 | ||||||
Long-term liabilities: |
||||||||
Restructuring liability |
13,610 | 62,330 | ||||||
Deferred revenue |
320,167 | 163,754 | ||||||
Total long-term liabilities |
333,777 | 226,084 | ||||||
Total liabilities |
$ | 4,547,754 | $ | 4,910,542 | ||||
Minority interest |
$ | 392,799 | $ | | ||||
Commitments and contingencies |
||||||||
Stockholders equity: |
||||||||
Common stock, $0.01 par value, 200,000,000
shares authorized, 179,191,042 and 172,358,223
shares issued and outstanding |
1,791,910 | 1,723,582 | ||||||
Additional paid-in capital |
171,993,118 | 163,362,829 | ||||||
Foreign currency translation |
448,893 | 430,502 | ||||||
Accumulated deficit |
(162,104,961 | ) | (149,607,388 | ) | ||||
Total stockholders equity |
$ | 12,128,960 | $ | 15,909,525 | ||||
Total liabilities and stockholders equity |
$ | 17,069,513 | $ | 20,820,067 | ||||
The accompanying notes are an integral part of these
condensed consolidated financial statements
3
XYBERNAUT CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(UNAUDITED)
Three Months Ended September 30, |
Nine Months Ended September 30, |
|||||||||||||||
2004 |
2003 |
2004 |
2003 |
|||||||||||||
Revenue: |
||||||||||||||||
Hardware |
$ | 1,587,442 | $ | 1,621,532 | $ | 6,453,475 | $ | 4,222,036 | ||||||||
Consulting, licensing and other |
1,657,400 | 1,081,589 | 4,566,412 | 3,056,643 | ||||||||||||
Total revenue |
3,244,842 | 2,703,121 | 11,019,887 | 7,278,679 | ||||||||||||
Cost of sales: |
||||||||||||||||
Hardware |
1,461,584 | 1,302,490 | 5,917,636 | 3,124,741 | ||||||||||||
Consulting, licensing and other |
893,562 | 690,998 | 2,547,216 | 1,920,859 | ||||||||||||
Provision for inventory and tooling |
| 1,500,000 | | 3,249,354 | ||||||||||||
Gross income / (loss) |
889,696 | (790,367 | ) | 2,555,035 | (1,016,275 | ) | ||||||||||
Operating expenses: |
||||||||||||||||
Sales and marketing |
3,516,368 | 2,058,762 | 9,449,880 | 6,199,691 | ||||||||||||
General and administrative |
1,250,291 | 1,042,583 | 3,205,126 | 3,023,217 | ||||||||||||
Research and development |
789,197 | 708,520 | 2,742,298 | 2,708,848 | ||||||||||||
Total operating expenses |
5,555,856 | 3,809,865 | 15,397,304 | 11,931,756 | ||||||||||||
Operating loss |
(4,666,160 | ) | (4,600,232 | ) | (12,842,269 | ) | (12,948,031 | ) | ||||||||
Interest and other income / (expense), net |
20,244 | (74,007 | ) | 86,828 | (361,552 | ) | ||||||||||
Loss before minority interest |
(4,645,916 | ) | (4,674,239 | ) | (12,755,441 | ) | (13,309,583 | ) | ||||||||
Minority interest |
103,690 | | 257,868 | | ||||||||||||
Net loss |
$ | (4,542,226 | ) | $ | (4,674,239 | ) | $ | (12,497,573 | ) | $ | (13,309,583 | ) | ||||
Net loss per share (basic and diluted) |
$ | (0.03 | ) | $ | (0.03 | ) | $ | (0.07 | ) | $ | (0.10 | ) | ||||
Weighted average number of shares
outstanding (basic and diluted) |
179,160,879 | 158,635,685 | 176,637,760 | 138,485,139 | ||||||||||||
The accompanying notes are an integral part of these
condensed consolidated financial statements
4
XYBERNAUT CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW
(UNAUDITED)
Nine Months Ended September 30, |
||||||||
2004 |
2003 |
|||||||
Cash flows from operating activities: |
||||||||
Net loss |
$ | (12,497,573 | ) | $ | (13,309,583 | ) | ||
Adjustments to reconcile net loss to net cash used in
operating activities: |
||||||||
Depreciation and amortization |
760,724 | 1,520,926 | ||||||
Provision for bad debts |
100,000 | | ||||||
Provision for inventory and tooling |
| 3,249,354 | ||||||
Loss on disposal of assets |
| 38,341 | ||||||
Non-cash charges for equity securities issued for services |
123,467 | 202,980 | ||||||
Amortization of note discount |
| 393,594 | ||||||
Minority interest |
(257,868 | ) | | |||||
Changes in assets and liabilities: |
||||||||
Inventory |
(23,914 | ) | (2,815,251 | ) | ||||
Accounts receivable |
1,576,056 | 1,228,285 | ||||||
Prepaid and other current assets |
(1,633,138 | ) | 130,906 | |||||
Other assets |
146,784 | (59,852 | ) | |||||
Accounts payable |
(594,565 | ) | (775,453 | ) | ||||
Accrued expenses and other |
230,927 | (53,906 | ) | |||||
Deferred revenue, current |
38,352 | 268,445 | ||||||
Restructuring liability, long-term |
(47,438 | ) | (60,641 | ) | ||||
Deferred revenue, long-term |
15,556 | (69,315 | ) | |||||
Net cash used in operating activities |
$ | (12,062,630 | ) | $ | (10,111,170 | ) | ||
Cash flows from investing activities: |
||||||||
Acquisition of property, equipment and demonstration units |
(608,080 | ) | (256,012 | ) | ||||
Acquisition of patents and trademarks |
(308,802 | ) | (211,156 | ) | ||||
Restricted cash |
550,804 | (376,111 | ) | |||||
Capitalization of tooling costs |
| (20,000 | ) | |||||
Net cash used in investing activities |
$ | (366,078 | ) | $ | (863,279 | ) | ||
Cash flows from financing activities: |
||||||||
Proceeds from: |
||||||||
Common stock offerings, net |
5,961,440 | 13,770,035 | ||||||
Exercise of warrants |
2,541,317 | 6,445,343 | ||||||
Exercise of stock options |
65,717 | 26,878 | ||||||
Notes and loans |
| 1,750,000 | ||||||
Payments for: |
||||||||
Capitalization of loan costs |
| (18,376 | ) | |||||
Net cash provided by financing activities |
$ | 8,568,474 | $ | 21,973,880 | ||||
Effect of exchange rate changes on cash and cash equivalents |
343,230 | 95,912 | ||||||
Net (decrease) / increase in cash and cash equivalents |
(3,517,004 | ) | 11,095,343 | |||||
Cash and cash equivalents, beginning of period |
9,524,541 | 1,967,710 | ||||||
Cash and cash equivalents, end of period |
$ | 6,007,537 | $ | 13,063,053 | ||||
Supplemental disclosure of cash flow information: |
||||||||
Cash paid for interest |
$ | 579 | $ | 579 | ||||
Cash paid for taxes |
$ | 631 | $ | 585 | ||||
Supplemental disclosure of non-cash financing activities: |
||||||||
Equity securities issued for services rendered, expensed
in periods issued |
$ | 123,467 | $ | 202,980 | ||||
Equity securities issued for settlement of notes payable |
$ | | $ | 1,661,000 | ||||
The accompanying notes are an integral part of these
condensed consolidated financial statements
5
XYBERNAUT CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
1. BASIS OF PRESENTATION
The accompanying unaudited, condensed and consolidated financial statements of Xybernaut Corporation, a Delaware Corporation (the Company), have been prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP) for interim financial information and instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, these statements do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of the Companys management, these unaudited, condensed and consolidated financial statements reflect all adjustments of a normal, recurring nature necessary to present fairly the financial position of the Company and its subsidiaries at September 30, 2004 and December 31, 2003, the results of their operations for the three and nine months ended September 30, 2004 and 2003 and cash flows for the nine months ended September 30, 2004 and 2003. Results of operations for the three and nine months ended September 30, 2004 are not necessarily indicative of results of operations expected for the full fiscal year ending December 31, 2004. Please refer to the Companys Annual Report on Form 10-K, as amended on Form 10-K/A, for the complete financial statements for the period ended December 31, 2003.
2. THE COMPANY, LIQUIDITY AND OPERATIONS
The Company is engaged in the research, development, manufacture, marketing and sale of mobile/wearable computing and communication systems as well as software and service solutions designed to enhance productivity and improve product management, asset management, and the accuracy, timeliness and utilization of critical enterprise data. The Company offers solutions with a software and services focus through its wholly-owned subsidiary Xybernaut Solutions, Inc. (U.S.). The Company offers solutions with a hardware focus through its U.S. operations and through its wholly-owned subsidiaries Xybernaut K.K. (Japan) and Xybernaut GmbH (Germany). In February 2004, the Company began actively marketing its mobile and wearable hardware solutions in the Peoples Republic of China through its 60% ownership in Xybernaut China Limited, a joint venture with Softbank Investment International (Strategic) Ltd. (Xybernaut China). The Company was originally incorporated in 1990 and completed its initial public offering in July 1996.
Introduced in 1995, the Mobile Assistant® (MA®) series is the Companys primary line of wearable computer hardware products, the current versions of which are the MA V and MA TC. Introduced in 2002, the Atigo product line is a family of mobile wireless web panels that can be used either as stand-alone handheld personal computers (PCs) or as displays for an MA system, a laptop or a conventional PC. Since their commercial introductions, the Company has recognized revenue of approximately $32,000,000 on sales of approximately 9,700 MA and Atigo systems.
The Company has recorded net losses since its inception. These losses are primarily attributable to the operating expenses incurred by the Company to design, develop, market and sell its mobile and wearable computer products and to provide general and administrative support for these operating activities. The Companys revenues and gross margins have not been sufficient to fund these operating activities. As a result, the Company has consistently reported negative cash flows from operating activities and net losses and had an accumulated deficit of $162,104,961 at September 30, 2004.
The Companys management has taken steps that it believes are necessary to improve operations and raise additional capital, both of which are needed to meet its cash flow needs through December 31, 2004 and thereafter. During 2002 and 2003, management performed reviews of the Companys operations and implemented various cost cutting programs to reduce the Companys operating expenses to better align costs with current and expected business volume. Management believes that the Companys current staffing and resources will be sufficient to carry out its business plan for the foreseeable future.
The Companys management believes that the combination of cash on hand, cash flows from operations and outside additional funding from third party investors will provide sufficient liquidity to meet the Companys ongoing cash requirements. This is based on the Companys historical ability to raise funds in the form of debt and equity financings. However, there can be no assurance that the Company can or will obtain sufficient funds from operations or from additional financings on terms acceptable to the Company. If the Company is unable to obtain sufficient additional financing, it will be required to reduce spending in order to maintain its operations at a reduced level. Management believes that it would be able to reduce spending if required, however, there can be no assurances that it can successfully do so.
3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Use of Estimates in the Preparation of Financial Statements
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
6
Cash, Cash Equivalents and Restricted Cash
The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. At September 30, 2004 and December 31, 2003, the Company had $706,750 and $1,257,554, respectively, in restricted cash. The balance at September 30, 2004 consisted of a i) $500,000 cash deposit that secures a long-term services contract and ii) $206,750 cash supersedeas bond furnished in July 2004 to the Denver District Court related to pending litigation. The balance at December 31, 2003 consisted of i) this same $500,000 cash deposit, ii) a $376,442 cash deposit and interest that secured a letter of credit held by a vendor and iii) $381,112 held in escrow representing a December 2003 payment made by the Company for inventory that was delivered during 2004. The restrictions on the $500,000 deposit are scheduled to lapse in the middle of 2005, at which point the cash deposit is expected to be returned to the Company. The restrictions on the $376,442 deposit lapsed in the first quarter of 2004 and the amount was returned to the Companys unrestricted cash balance. The $381,112 escrow balance was remitted to the vendor as the inventory was delivered during the first quarter of 2004.
Inventory and Tooling
At September 30, 2004, inventory consisted primarily of wearable computer component parts held for resale and allocated tooling costs, and is comprised primarily of finished goods. Capitalized tooling costs consist of payments made to third-party vendors for their products and services that are used in the manufacture of the Companys proprietary hardware products. Tooling costs are allocated to inventory or property and equipment and are amortized as a component of cost of sales or depreciation based upon the number of units sold or used as demonstration units in a given period compared to the total number of units expected in a products production run. Inventory and tooling are stated at the lower of cost or market, with cost being determined on a first-in, first-out basis. Management periodically assesses the need to provide for obsolescence of inventory and tooling and adjusts the carrying value to its net realizable value when required.
During the nine months ended September 30, 2003, the Company recognized a $3,249,354 charge on its consolidated statement of operations related to reserves established against its MA V inventory, related components and tooling. The Company did not recognize any such charges during the 2004 period.
The Company had a $3,272,716 inventory reserve on its consolidated balance sheet at both September 30, 2004 and December 31, 2003. This balance represents a $3,022,716 reserve against MA V systems and a $250,000 reserve against MA TC systems.
The Companys management believes that it can sell its mobile/wearable computer inventory at amounts that approximate current net carrying values, which have been reduced as a result of the above charges. To determine the size of the charges to record, management reviewed the carrying value of its inventory in light of the introduction of new product lines, its ability to sell the quantities of inventory on hand as well as the quantities expected to be received in the future and the sales prices it ultimately expects to achieve. This analysis took into account estimated price concessions which management believes are likely to be necessary in disposing of this inventory. The significant majority of the Companys recent inventory and tooling charges were recorded against the MA V product line. Even after the successful renegotiation of certain of the MA V manufacturing contracts during 2003, the Company had commitments to purchase significant quantities of inventory. The Company was required to write-down and reserve a substantial portion of the MA V inventory as historical and forecasted sales were not sufficient to sell such quantities of inventory. As a result of this review, it was determined that certain of the Companys inventory was slow-moving, risked becoming obsolete or would likely be sold at below its historical cost. Based upon a specific review of the carrying costs for the inventory items, management estimated the quantity of each inventory item that the Company was expected to be able to sell and also quantified inventory amounts that may not be recoverable. To the extent that actual future events are different from the assumptions and estimates used by management, additional charges, reserves or adjustments may be recorded by the Company. Management does not expect to record significant profits or losses upon the ultimate sale of the Companys inventory that has been written down or reserved.
As of September 30, 2004, net of the effect of reserves and write-offs, the Companys inventory consisted of $933,941 in MA V systems, $331,386 in MA TC systems and $1,372,018 in Atigo systems. As of December 31, 2003, all of the Companys tooling assets had been allocated to inventory or property and equipment. Capitalized tooling costs during the nine months ended September 30, 2004 and 2003 were $0 and $20,000, respectively. Amortization to cost of goods sold or depreciation, depending on classification of tooling costs as inventory or property and equipment, was $10,243 and $124,006 for the three and nine months ended September 30, 2004 and $180,943 and $299,431 for the three and nine months ended September 30, 2003, respectively.
7
Stock-Based Compensation
In December 2002 the Financial Accounting Standards Board issued Statement of Financial Accounting Standards (SFAS) No. 148, Accounting for Stock Based Compensation-Transition and Disclosure, an amendment to SFAS No. 123, Accounting for Stock-Based Compensation. SFAS No. 148 amends the disclosure provisions to require prominent disclosure about the effects on reported net income of an entitys accounting policy decisions with respect to stock-based compensation. Stock options are accounted for using the intrinsic method in accordance with Accounting Principles Board No. 25, Accounting for Stock Issued to Employees, as interpreted, whereby if options are priced at fair market value or above at the date of grant, no compensation expense is recognized. The pro forma information is as follows:
Three Months Ended September 30, |
Nine Months Ended September 30, |
|||||||||||||||
2004 |
2003 |
2004 |
2003 |
|||||||||||||
Net loss, as reported |
$ | (4,542,226 | ) | $ | (4,674,239 | ) | $ | (12,497,573 | ) | $ | (13,309,583 | ) | ||||
Stock-based employee compensation under the
intrinsic value method included in net loss as reported |
5,521 | | 28,475 | 150,325 | ||||||||||||
Stock-based employee compensation under fair value
method of SFAS No. 123 |
(168,482 | ) | (473,931 | ) | (450,838 | ) | (1,367,389 | ) | ||||||||
Net loss pro forma |
$ | (4,705,187 | ) | $ | (5,148,170 | ) | $ | (12,919,936 | ) | $ | (14,526,647 | ) | ||||
Net loss per share basic and diluted as reported |
$ | (0.03 | ) | $ | (0.03 | ) | $ | (0.07 | ) | $ | (0.10 | ) | ||||
Net loss per share basic and diluted pro forma |
$ | (0.03 | ) | $ | (0.03 | ) | $ | (0.07 | ) | $ | (0.10 | ) | ||||
Issuance of Equity Securities for Services
The Company periodically issues equity securities to certain employees, consultants and companies for services provided to, or goods received by, the Company. These securities include shares of common stock and warrants and options to purchase shares of common stock. These transactions were individually valued based upon the fair value of the securities issued or the services or goods provided, whichever was more reliably measured. For the three months and nine months ended September 30, 2004, equity securities related to consulting services and employee severance were issued in payment of $38,883 and $123,467, respectively, compared to $39,905 and $202,980 for the same periods in 2003.
Reclassifications
Certain 2003 balances and disclosures have been reclassified to conform to the 2004 presentation.
4. BORROWINGS
On March 26, 2003, the Company borrowed $1,750,000 from a lender pursuant to a one-year promissory note which accrued interest at 3.5% per annum. In connection with this borrowing, the Company issued to the lender warrants to purchase 1,750,000 shares of common stock at an exercise price of $1.25 per share and warrants to purchase 2,000,000 shares of common stock at an exercise price of $0.43 per share. Based on the relative fair values of the securities issued, these warrants were assigned a value of $393,594, which amount was recorded as a note discount and amortized into interest expense over the life of the note. On May 30, 2003, the Company repaid $860,000 in principal when the lender elected to exercise the 2,000,000 warrants at $0.43 per share. Subsequent to this partial repayment, the lender provided the Company with a 10% discount on the remaining unpaid principal to induce the Company to repay the remaining principal prior to its original maturity date. The remaining principal and interest was repaid on May 30, 2003 through the: i) $89,000 discount, which was applied against the Companys Additional Paid-In Capital, ii) application of the $560,000 aggregate exercise price related to the exercise of the warrants to purchase 1,750,000 shares of common stock at $0.32 per share, a reduction from the original $1.25 per share exercise price, iii) issuance of 651,351 shares of common stock valued at $241,000, or $0.37 per share, and iv) issuance of 30,350 shares of common stock valued at $11,229, or $0.37 per share, as repayment of accrued interest. During the three and nine months ended September 30, 2003, the Company recorded interest expense of $0 and $11,229, respectively. During the three and nine months ended September 30, 2003, the Company recorded amortization of note discount of $0 and $393,594, respectively. The Company had no outstanding principal or interest related to this note at September 30, 2004 or December 31, 2003.
5. MINORITY INTEREST
In February 2004, the Company began actively marketing its mobile and wearable hardware solutions in the Peoples Republic of China (the PRC) through Xybernaut China, a joint venture with Softbank Investment International (Strategic) Ltd. (Softbank Strategic). The Company owns 60% of Xybernaut China and Softbank Strategic owns the remaining 40%. Xybernaut China has the exclusive right to manufacture, market, sell and distribute the Companys products throughout the PRC. The Company has assigned all of its existing agreements and relationships in the PRC to Xybernaut China and is providing it with certain limited management resources, know-how and technical assistance. The Company has licensed its intellectual property to Xybernaut China for a five year period. Softbank Strategic is providing the start-up funding for Xybernaut China and is assisting with its day-to-day operations. The Companys consolidated financial statements for the three and nine months ended September 30, 2004 include the operations of Xybernaut China. During the nine months ended September 30, 2004, Softbank Strategic provided funding to Xybernaut China of $650,667, which amount was recorded as Minority Interest on the Companys consolidated balance sheet net of foreign currency fluctuation and reduced by Softbank Strategics $257,868 share of Xybernaut Chinas net loss.
8
6. STOCKHOLDERS EQUITY
During February 2003, the Company received gross proceeds of $2,000,000 through a private placement of 6,666,667 shares of its common stock to an investor. In connection with this private placement, the Company issued to the investor callable warrants to purchase 3,333,333 shares of common stock at an exercise price of $1.25 per share.
During May 2003, the Company received gross proceeds of $3,000,000 through a private placement of 9,375,000 shares of its common stock to certain investors. In connection with this private placement, the Company issued to the investors three-year callable warrants to purchase 3,281,250 shares of common stock. These warrants had an exercise price of $0.45 if exercised in the first year, $0.90 if exercised in the second year and $1.35 if exercised in the third and final year.
During June 2003, the Company received gross proceeds of $2,000,000 through a private placement of 5,405,405 shares of its common stock to an investor. In connection with this private placement, the Company issued to the investor three-year callable warrants to purchase 4,054,054 shares of common stock. These warrants had an exercise price of $1.25 if exercised in the first year, $2.50 if exercised in the second year and $3.75 if exercised in the third and final year.
During September 2003, the Company received gross proceeds of $5,000,000 through a private placement of 6,849,315 shares of its common stock to an investor. In connection with this private placement, the Company issued to the investor three-year callable warrants to purchase 3,424,658 shares of common stock. These warrants had an exercise price of $0.91 if exercised in the first year, $1.82 if exercised in the second year and $2.73 if exercised in the third and final year.
During September 2003, the Company received gross proceeds of $2,000,000 through a private placement of 1,600,000 shares of its common stock to an investor. In connection with this private placement, the Company issued to the investor three-year callable warrants to purchase 800,000 shares of common stock. These warrants have an exercise price of $1.25 if exercised in the first year, $2.50 if exercised in the second year and $3.75 if exercised in the third and final year.
During March 2004, the Company received gross proceeds of $5,000,000 through the private placement of 3,731,343 shares of its common stock to an investor. In connection with this private placement, the Company issued to the investor three-year callable warrants to purchase 1,865,671 shares of common stock at $1.52 per share and six-month callable warrants to purchase 1,865,671 shares of common stock at $1.52 per share.
During March 2004, the Company received gross proceeds of $1,000,000 through the private placement of 662,252 shares of its common stock to an investor. In connection with this private placement, the Company issued to the investor three-year callable warrants to purchase 331,126 shares of common stock at $1.52 per share and six-month callable warrants to purchase 331,126 shares of common stock at $1.52 per share.
The Company issues warrants to purchase shares of its common stock, primarily in connection with the Companys financings and borrowings. Exclusive of the transactions discussed in Borrowings above, the Company received through the exercise of warrants net proceeds of $0 and $2,541,317 through the issuance of 0 and 2,221,797 shares of its common stock during the three and nine months ended September 30, 2004, respectively, and proceeds of $3,191,176 and $6,445,343 through the issuance of 7,722,768 and 19,597,769 shares of its common stock during the three and nine months ended September 30, 2003, respectively. Concurrently with their exercise during the nine months ended September 30, 2004, the exercise price of 2,196,797 of the warrants was reduced from a weighted average of $1.52 per share to $1.15 per share. Concurrently with their exercise during the nine months ended September 30, 2003, the exercise price of 16,316,852 of the warrants was reduced from a weighted average of $1.13 per share to $0.31 per share. At September 30, 2004, the Company had warrants outstanding to purchase 6,289,536 shares of its common stock at prices that range from $0.70 to $5.00 per share, with a weighted average of $2.86 per share.
Employees and consultants of the Company have exercised stock options that had been issued pursuant to the Companys various stock incentive plans. During the nine months ended September 30, 2004 and 2003, the Company received net proceeds of $65,717 and $26,878, respectively, and issued 132,418 and 111,995 shares of its common stock, respectively, related to these exercises.
9
7. SEGMENT AND ENTERPRISE WIDE REPORTING
The Company discloses certain financial and supplementary information about its operating segments, products and services, geographic areas and major customers pursuant to SFAS No. 131, Disclosures about Segments of an Enterprise and Related Information. Operating segments are defined as components of an enterprise about which separate discrete financial information is evaluated regularly by the chief operating decision maker or decision making group, in deciding how to allocate resources and assess performance. The financial information disclosed herein materially presents all of the financial information related to the Companys principal operating segments as a provider of mobile/wearable computing and communications systems and software and service solutions.
Revenues by geographical destination as a percentage of total revenues are as follows:
For the Three Months Ended | For the Nine Months Ended | ||||||||||||||||||
September 30, |
September 30, |
||||||||||||||||||
2004 |
2003 |
2004 |
2003 |
||||||||||||||||
North America |
79 | % | 87 | % | 79 | % | 86 | % | |||||||||||
Europe |
16 | % | 11 | % | 16 | % | 11 | % | |||||||||||
Asia, excluding China |
3 | % | 2 | % | 3 | % | 3 | % | |||||||||||
China |
2 | % | 0 | % | 2 | % | 0 | % |
Operations in various geographical areas are summarized as follows:
As of and for the | As of and for the | |||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
September 30, |
September 30, |
|||||||||||||||
2004 |
2003 |
2004 |
2003 |
|||||||||||||
North America: |
||||||||||||||||
Total revenue |
$ | 2,553,316 | $ | 2,372,537 | $ | 8,791,560 | $ | 6,265,164 | ||||||||
Net loss |
3,880,154 | 4,346,372 | 10,811,138 | 12,289,793 | ||||||||||||
Identifiable assets |
14,167,787 | 20,093,756 | 14,167,787 | 20,093,756 | ||||||||||||
Europe (1): |
||||||||||||||||
Total Revenue |
$ | 514,127 | $ | 288,050 | $ | 1,713,967 | $ | 803,056 | ||||||||
Net loss |
470,174 | 277,212 | 1,199,415 | 932,326 | ||||||||||||
Identifiable assets |
2,414,948 | 1,072,214 | 2,414,948 | 1,072,214 | ||||||||||||
Asia, excluding China: |
||||||||||||||||
Total revenue |
$ | 107,693 | $ | 42,534 | $ | 338,841 | $ | 210,459 | ||||||||
Net loss |
36,372 | 50,655 | 100,228 | 87,464 | ||||||||||||
Identifiable assets |
376,203 | 425,359 | 376,203 | 425,359 | ||||||||||||
China (2): |
||||||||||||||||
Total revenue |
$ | 69,706 | $ | | $ | 175,519 | $ | | ||||||||
Net loss |
155,526 | | 386,792 | | ||||||||||||
Identifiable assets |
110,575 | | 110,575 | |
(1) Included in the Companys operations in Europe for the three months and nine months ended September 30, 2004, were expenses related to research and development activities conducted by a branch of the Company operating in Germany of $115,286 and $318,149, respectively, compared to $61,132 and $178,208 for the same periods in 2003.
(2) The Companys operations in China include minority interest of $103,690 and $257,868 for the three and nine months ended September 30, 2004, respectively.
10
8. TRANSACTIONS WITH RELATED AND CERTAIN OTHER PARTIES
The following table summarizes the number of customers that individually comprise greater than 10% of total revenue or total accounts receivable and their aggregate percentage of the Companys total revenue or total accounts receivable.
As of and for the Three | As of and for the Nine | |||||||||||||||
Months Ended September 30, |
Months Ended September 30, |
|||||||||||||||
2004 |
2003 |
2004 |
2003 |
|||||||||||||
Revenue: |
||||||||||||||||
Number of Customers |
1 | 2 | 2 | 2 | ||||||||||||
Percent of Total Revenue |
12 | % | 43 | % | 25 | % | 38 | % | ||||||||
Accounts Receivable: |
||||||||||||||||
Number of Customers |
1 | 2 | 1 | 2 | ||||||||||||
Percent of Total Accounts Receivable |
26 | % | 48 | % | 26 | % | 48 | % |
Xybernaut China has entered into an agreement with New Tech & Telecom Investment Ltd. (New Tech & Telecom). Softbank Strategic, the Companys joint venture partner in Xybernaut China, is a significant investor in New Tech & Telecom. Under the terms of the agreement, New Tech & Telecom provides Xybernaut China with certain operating services (including sales, marketing, business development, product, fulfillment, accounting and secretarial) and general and administrative resources (including office space, information technology, telecommunications and insurance). Xybernaut China is charged fees totaling approximately $32,000 per month for such services. The Company believes that it is able to more effectively and quickly start up operations in the PRC by outsourcing the majority of its operations to New Tech & Telecom, which already has a presence and relationships within the PRC. The Company also evaluated the cost and time required if the Company performed these services in-house, including expenses and activities related to salary and benefits, recruitment, training, rent and other overhead. As a result, the Companys management believes that the arrangement with New Tech & Telecom contains reasonable terms and conditions. Unrelated to the above agreement, New Tech & Telecom purchased approximately $76,000 in mobile computing products from the Company during the nine months ended September 30, 2004.
Certain of the end-users of the Companys wearable computer products are universities and other not-for-profit entities (collectively, the End-Users) that purchase these products from a Value Added Reseller (the VAR) of Xybernaut GmbH. The Company also contracts with certain of the End-Users to provide research and development and sales and marketing services to the Company. The research and development services provided to the Company include activities such as hardware and software development, product testing and evaluation. The sales and marketing services include activities such as Company participation in and sponsorship of industry trade shows, the preparation of competitive market analysis and the use of the End-Users as named reference accounts. During the three months and nine months ended September 30, 2004, the Company recorded revenues of approximately $106,000 and $363,000, respectively, related to sales of its products to the VAR. During the three and nine months ended September 30, 2004, the Company recorded total research and development and sales and marketing expenses of approximately $29,000 and $344,000, respectively, related to services performed by the End-Users. During the three months and nine months ended September 30, 2003, the Company recorded revenues of approximately $163,000 and $577,000, respectively, related to sales of its products to the VAR. During the three and nine months ended September 30, 2003, the Company recorded total research and development and sales and marketing expenses of approximately $181,000 and $591,000, respectively, related to services performed by the End-Users. The Company compares the cost of the projects performed by the End-Users against the cost it would likely incur if it were to obtain these services from entities other than the End-Users. Management also evaluates the cost if the Company performed these services in-house, including expenses that would be incurred for salary and benefits, training, travel, supplies and equipment, and overhead. As a result, the Companys management believes that the agreements and contracts underlying both the sale of the products and the performance of the services contain reasonable terms and conditions.
11
9. SUBSEQUENT EVENT
The Company entered into a Development, Manufacturing and Distribution Agreement dated as of November 1, 2004 (the Manufacturing Agreement) with Shenzhen Sunshine Hi-Tech Co. Ltd. (Sunshine), pursuant to which, among other things, Sunshine has agreed to develop and manufacture, at its most favorable prices, current and future products on behalf of the Company, in accordance with the Companys specifications and technical requirements, for an initial five year term. With respect to products developed to the Companys satisfaction, the Company shall have a royalty-free license to market such products worldwide, excluding the PRC, and Xybernaut China and Sunshine shall have a royalty-free license (which is non-assignable in the case of Sunshine) to market such products in the PRC. Sunshine has also guaranteed to invest adequate funding in manufacturing of products as required by the Company. Under the Manufacturing Agreement, Sunshine also granted the Company an exclusive license to sell Sunshines operating system, which is used in China, when used with existing or future Company products, throughout the world (other than the PRC) for a royalty.
In connection with, and as a part of the Manufacturing Agreement the Company entered into a Securities Exchange Agreement dated as of November 1, 2004, as a supplementary agreement (the Exchange Agreement), with the majority stockholders of Sunshine (the Investor Group) pursuant to which, among other things, the Company, or at its option, Xybernaut China, acquired twenty-four and nine-tenths percent (24.9%) of the equity interests of Sunshine, on an as converted, fully diluted basis, in exchange for the issuance to the Investor Group of such number of restricted shares of the Companys common stock, par value $0.01 per share, having a market value of US$2,000,000, which number of shares was based upon the average closing price of the Companys common stock on the NASDAQ SmallCap Market for the twenty (20) trading days immediately prior to the closing under the Exchange Agreement.
The other documentation for the transaction provides that the Company has the right to designate one member to the Board of Directors of Sunshine and additional directors under certain circumstances. In addition, the Company has the right to purchase additional equity securities of Sunshine to maintain its percentage equity interest and the right to include its securities on any registration or listing of Sunshine common stock for sale in any public marketplace. In connection with the Exchange Agreement, the Company executed a Registration Rights Agreement, dated as of November 1, 2004, by and between the Company and the Investor Group, pursuant to which the Company is obligated to use reasonable efforts to file a registration statement to register for resale the shares of common stock issued to the Investor Group with the Securities and Exchange Commission on or before December 31, 2004, and use its best efforts to cause such registration statement to be declared effective by the Securities and Exchange Commission not later than January 30, 2005.
12
ITEM 2. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
FORWARD-LOOKING STATEMENTS
To keep investors informed of the Companys future plans and objectives, this Quarterly Report on Form 10-Q and other reports and statements issued by the Company and its officers from time to time contain certain statements concerning the Companys future results, future performance, intentions, objectives, plans and expectations that are, or may be deemed to be, forward-looking statements. The Companys ability to do this has been fostered by the Private Securities Litigation Reform Act of 1995 which provides a safe harbor for forward-looking statements to encourage companies to provide prospective information so long as those statements are accompanied by meaningful cautionary statements identifying important factors that could cause actual results to differ materially from those discussed in the statement. Such forward-looking statements are subject to a number of known and unknown risks and uncertainties that, in addition to general economic and business conditions, could cause the Companys actual results, performance, and achievements to differ materially from those described or implied in the forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, the Companys ability to execute its business strategy, to profit from its products and services as expected, to compete, to maintain superior technological capability, to foresee changes and to continue to identify, develop and commercialize innovative and competitive products and services, to penetrate different markets and successfully expand its revenue, to attract and retain technologically qualified personnel, particularly in the areas of sales and research and development, and the Companys ability to generate such cash flow and obtain financing to support its operations and growth (see generally Managements Discussion and Analysis of Financial Condition and Results of Operations and Liquidity and Capital Resources contained therein) and other risks described in this Quarterly Report on Form 10-Q and other filings with the SEC.
OVERVIEW
Xybernaut Corporation, a Delaware corporation (the Company), is engaged in the research, development, manufacture, marketing and sale of mobile/wearable computing and communication systems as well as software and service solutions designed to enhance productivity and improve product management, asset management, and the accuracy, timeliness and utilization of critical enterprise data. The Company offers solutions with a software and services focus through its wholly-owned subsidiary Xybernaut Solutions, Inc. (Virginia, U.S.). The Company offers solutions with a hardware focus through its U.S. operations and through its wholly-owned subsidiaries Xybernaut K.K. (Yokohama, Japan) and Xybernaut GmbH (Böblingen, Germany). In February 2004, the Company began actively marketing its mobile and wearable hardware solutions in the Peoples Republic of China through its 60% ownership in Xybernaut China Limited (Hong Kong, China), a joint venture with Softbank Investment International (Strategic) Ltd. (Softbank Strategic). The Company was originally incorporated in 1990 and completed its initial public offering in July 1996.
The consolidated financial statements include the accounts of the Company and its subsidiaries: Xybernaut Solutions, Inc. (XSI), Xybernaut K.K., Xybernaut GmbH and Xybernaut China Limited (Xybernaut China). All significant intercompany accounts and transactions have been eliminated in the consolidation.
Introduced in 1995, the Mobile Assistant® (MA®) series is the Companys primary line of wearable computer hardware products, the current versions of which are the MA V and MA TC. Introduced in 2002, the Atigo product line is a family of mobile wireless web panels that can be used either as stand-alone handheld personal computers (PCs) or as displays for an MA system, a laptop or a conventional PC. Since their commercial introductions, the Company has recognized revenue of approximately $32,000,000 on sales of approximately 9,700 MA and Atigo systems. The Company derives its revenues from sales of its mobile/wearable computers and software products, consulting services and licensing of its intellectual property.
A number of trends are expected to have a significant effect on the Companys operations in the future. In the past, many of the Companys large customers deferred or delayed anticipated purchases of the Companys products because of uncertain economic conditions and other concerns. Regardless of economic conditions, potential customers may have concerns about purchases from smaller vendors. While the Company believes that general economic conditions began to improve during 2004 and expects that they will continue to improve during 2005, there can be no assurance that this expectation will be realized. If economic conditions and issues persist or worsen, it is possible that more potential customers will delay or cancel purchases, which would have an adverse effect on the Companys revenues and operations.
13
A significant percentage of the Companys revenues has typically been concentrated among a relatively small number of customers. As a result, it is more likely that the Companys revenues will fluctuate from period to period than if the Company had a larger number of smaller sales. This also makes it more difficult for the Company to accurately forecast future revenues. Significant quarterly fluctuations can occur, for example, if the Company ships a large hardware order at the beginning of one quarter as opposed to the end of the preceding quarter.
Beginning with the widespread use of the internet on desktop computers, there has been an increasing demand for mobile computing and wireless communications devices that can bring the desktop internet experience to mobile users. The rapid growth of internet-enabled cell phones, PDAs, interactive pagers and similar products result in a growing number of devices that cater to the mobile data user and which may compete with the Companys products and which may also present opportunities for licensing in the future.
The Company believes that sales of its wearable and mobile computers rely to a large extent on the availability of wireless broadband services that can take advantage of the extensive processing power and display capabilities of the Companys hardware products. Wireless local area networks are now well established in commercial markets worldwide that provide broadband capabilities over a limited physical range in places such as corporate offices, warehouses, factory floors and airfields. However, wide-range wireless access that allows a user to move freely over large geographic areas and still maintain broadband access (commonly referred to as 3G) is still only widely available in certain areas, including Japan and parts of Europe. In July 2004, AT&T Wireless and NTT DoCoMo launched 3G service in four U.S. cities and plan to expand into additional U.S. cities in the future. The Company predicts that 3G service will be available in large metropolitan areas worldwide in the next few years. The Company believes that while the commercial markets can be successfully penetrated prior to the widespread introduction of wireless broadband access, such service will be needed prior to successful large-scale sales in the consumer markets.
RESULTS OF OPERATIONS
The following table sets forth certain consolidated financial data as a percentage of revenues:
Three Months Ended | Nine Months Ended | |||||||||||||||
September 30, |
September 30, |
|||||||||||||||
2004 |
2003 |
2004 |
2003 |
|||||||||||||
Revenue |
100 | % | 100 | % | 100 | % | 100 | % | ||||||||
Cost of sales |
73 | 74 | 77 | 69 | ||||||||||||
Provision for inventory and tooling |
0 | 55 | 0 | 45 | ||||||||||||
Gross income / (loss) |
27 | (29 | ) | 23 | (14 | ) | ||||||||||
Operating expenses: |
||||||||||||||||
Sales and marketing |
108 | 76 | 86 | 85 | ||||||||||||
General and administrative |
39 | 39 | 29 | 42 | ||||||||||||
Research and development |
24 | 26 | 25 | 37 | ||||||||||||
Total operating expenses |
171 | 141 | 140 | 164 | ||||||||||||
Interest and other income / (expense), net |
1 | (3 | ) | 1 | (5 | ) | ||||||||||
Minority interest |
3 | 0 | 2 | 0 | ||||||||||||
Net loss |
(140 | %) | (173 | %) | (113 | %) | (183 | %) | ||||||||
THREE MONTHS ENDED SEPTEMBER 30, 2004 AND SEPTEMBER 30, 2003
REVENUE. The Company derives its revenue from product sales of mobile/wearable computers and components, product sales of software, consulting services and licensing of its intellectual property. Total revenue for the three months ended September 30, 2004 was $3,244,842, an increase of $541,721, or 20%, compared to the three months ended September 30, 2003. This increase is due to the Companys consulting, licensing and other revenue which increased 53% to $1,657,400 for the three months ended September 30, 2004 compared to the same period in 2003. Included in consulting, licensing and other revenue in the third quarter of 2004 is $237,500 in cash received by the Company related to the settlement of a lawsuit for which the Company was the plaintiff that resulted in the grant of a non-exclusive license of one of the Companys Dual-Use Computing Device patents. No similar amounts were recorded in the 2003 period. The remaining increase in the Companys consulting, licensing and other revenue is due to increased consulting services in its U.S. operations on new consulting contracts and increased activity on existing contracts in 2004 compared with 2003. Sales from mobile/wearable computers decreased $34,090, or 2%, to $1,587,442 for the three months ended September 30, 2004 compared to 2003. This decrease in hardware sales is due to several factors. Hardware sales in the Companys U.S. operations decreased 24%, or $333,830, in the third quarter of 2004 compared with the same period in 2003. This fluctuation is due to a $597,934 decrease in 2004 sales of MA V systems compared to 2003 when the Company had a large sale of MA V systems. This decrease is offset by increases of $204,204 and $59,900 in U.S. sales of Atigo systems and Alternative Solutions sales, respectively, in the third quarter of 2004 compared to 2003. Alternative Solutions consist of sales of non-proprietary mobile/wearable hardware based on a customers specific needs and requirements. Hardware revenues in the Companys European operations increased $212,547 from the prior year. This growth was due to a large Atigo system sale in the third quarter of 2004 resulting in an increase of $374,367 compared to the same period in 2003. This increase was offset by a decrease in sales of MA V, MA IV and MA TC systems of $161,820. Hardware revenues from Japan, consisting primarily of MA V systems, in the third quarter of 2004 increased by $17,487 compared with the same period in 2003. Hardware revenues in China, consisting primarily of Atigo and MA V sales, were $69,706 and $0, respectively, during the three months ended September 30, 2004 and 2003.
14
COST OF SALES. The Companys cost of sales includes the costs of components for mobile/wearable computer systems, purchased software, direct labor and fringe, direct materials, amortization of tooling costs, warranty costs, fulfillment and shipping costs, and inventory and tooling reserves. Total cost of sales for the three months ended September 30, 2004 was $2,355,146, a decrease of $1,138,342, or 33%, compared to the three months ended September 30, 2003. Total gross margins were 27% and -29%, for the third quarter of 2004 and 2003, respectively. The negative 2003 gross margin was due to a $1,500,000 provision for inventory and tooling recorded in the third quarter of 2003 for which there is no such charge for the third quarter of 2004. Total gross margins, excluding the provision for inventory and tooling, were 27% and 26%, for the three months ended September 30, 2004 and 2003, respectively. Hardware cost of sales increased $159,094 for the third quarter of 2004 compared to the same period of in 2003, resulting in decreased hardware margins. Gross margins from hardware sales for the third quarter of 2004 were 8% compared to 20% for 2003. Third quarter 2004 hardware margins were negatively impacted by a large European sale of Atigo systems which was approximately break-even after initial discounts and also by a general decline in margins on other Atigo sales. Also contributing to the decrease in gross margins were Atigo and MA V systems provided free of charge for customer satisfaction purposes and unrecouped shipping charges totaling approximately $100,000. Absent these factors, hardware gross margins for the three months ended September 30, 2004 were 14%. Cost of sales from consulting, licensing and other activities increased $202,564, or 29%, in the third quarter of 2004 compared with 2003, which is less than the 53% increase in related revenue. As a result, consulting, licensing and other gross margins increased to 46% in 2004 from 36% in 2003. The increase is attributable to the $237,500 of licensing revenue recorded in 2004 related to the grant of a non-exclusive license of a patent for which there is no related cost of sales. Excluding this $237,500, gross margins on consulting, licensing and other activities remained consistent at 37% and 36% for the 2004 and 2003 third quarters, respectively.
SALES AND MARKETING EXPENSES. Sales and marketing expenses for the three months ended September 30, 2004 were $3,516,368, an increase of $1,457,606, or 71%, compared to the corresponding period in 2003. In the U.S. operations, sales and marketing expenses in the third quarter of 2004 relating to salaries, commissions, and benefits increased approximately $232,000 compared to the same period in 2003 due primarily to headcount increases. Additionally, costs related to travel of sales and sales operations personnel in the U.S. also increased approximately $261,000 supporting the Companys increase in headcount and sales activity. The U.S. operations also increased general marketing efforts by approximately $250,000 relating to consultants, meetings and promotional items and increased general brand marketing by approximately $195,000, consisting primarily of the sponsorship of the Alex Job Porsche Racing Team. Sales and marketing expenses also increased approximately $286,000 in the third quarter of 2004 compared to the same period in 2003 due to the start-up of Xybernaut China in the first quarter of 2004. In addition, sales and marketing expenses related to the Companys operations in Japan increased $48,000 due to an increase in headcount and expenses in Germany increased $95,000 due to an increase in headcount and commissions from increased sales.
GENERAL AND ADMINISTRATIVE EXPENSES. General and administrative expenses for the three months ended September 30, 2004 were $1,250,291, an increase of $207,708, or 20%, compared to the same period in 2003. Included in this increase was a $100,000 reserve recorded against accounts receivable in the third quarter of 2004. Additionally, legal expenses of $114,447 were incurred related to a lawsuit that resulted in the grant of a non-exclusive license of one of the Companys Dual-Use Computing Device patents.
RESEARCH AND DEVELOPMENT EXPENSES. The Companys research and development expenses consist primarily of personnel costs, the purchase of test equipment and payments to consultants and other third-parties which provide research and development services for mobile and wearable computing technologies. Research and development expenses for the three months ended September 30, 2004 were $789,197, an increase of $80,677, or 11%, compared to the corresponding period in 2003. Salaries and benefits in the Companys German operations decreased by $68,000 in the third quarter of 2004 compared to the same period in 2003. The Company also had an approximate $58,000 increase in expenditures to third parties and consultants for design and development of the Companys mobile/wearable product lines and a $58,000 increase in travel of personnel for the third quarter of 2004 compared to the third quarter of 2003.
INTEREST AND OTHER INCOME / EXPENSE, NET. Net interest and other income for the three months ended September 30, 2004 was $20,244, compared to net interest and other expense of $74,007 for the same period in 2003.
MINORITY INTEREST. Minority interest for the three months ended September 30, 2004 was $103,690, which represents Softbank Strategics share of the losses in Xybernaut China. The joint venture was formed during fiscal year 2004.
NET LOSS. As a result of the factors described above, the net loss for the three months ended September 30, 2004 was $4,542,226, a decrease of $132,013, or 3%, compared to the three months ended September 30, 2003.
15
NINE MONTHS ENDED SEPTEMBER 30, 2004 AND SEPTEMBER 30, 2003
REVENUE. The Company derives its revenue from product sales of mobile/wearable computers and components, product sales of software, consulting services and the licensing of its intellectual property. Total revenue for the nine months ended September 30, 2004 was $11,019,887, an increase of $3,741,208, or 51%, compared to the nine months ended September 30, 2003. Sales from mobile/wearable computers increased $2,231,439, or 53%, to $6,453,475 for the nine months ended September 30, 2004 compared to the same period in 2003. This growth in hardware revenues was driven by the Companys U.S. operations, which increased $1,178,619, or 35%. This net U.S. growth was due to increased Atigo and Alternative Solutions sales of $1,550,020 and $433,939, respectively, which were offset by a $805,340 decrease in sales of the Companys wearable computers, mainly MA V systems. Alternative Solutions consist of sales of non-proprietary mobile/wearable hardware based on a customers specific needs and requirements. European hardware sales increased 134%, or $868,913, in the first nine months of 2004 compared with the same period in 2003, due primarily to a large sale of Atigo systems. Hardware revenues from Japan, consisting primarily of MA V systems, in the first nine months of 2004 increased slightly by $8,388 compared with the same period in 2003. Hardware revenues in China, consisting of Atigo and MA V sales, were $92,058 and $83,461, respectively, for the nine months ended September 30, 2004 and $0 for the same period in 2003. The Companys consulting, licensing and other revenue for the nine months ended September 30, 2004 was $4,566,412, an increase of $1,509,769, or 49%, from 2003. Included in consulting, licensing and other revenue in the third quarter of 2004 is $237,500 in cash received by the Company related to the settlement of a lawsuit for which the Company was the plaintiff that resulted in the grant of a non-exclusive license of one of the Companys Dual-Use Computing Device patents. No similar amounts were recorded in the 2003 period. The remaining increase in the Companys consulting, licensing and other revenue of $1,272,269 is mainly due to increased consulting services in its U.S. operations on new consulting contracts and increased activity on existing contracts in 2004 compared with 2003.
COST OF SALES. The Companys cost of sales includes the costs of components for mobile/wearable computer systems, purchased software, direct labor and fringe, direct materials, amortization of tooling costs, warranty costs, fulfillment and shipping costs, and inventory and tooling reserves. Total cost of sales for the nine months ended September 30, 2004 was $8,464,852, an increase of $169,898, or 2%, compared to the same period in 2003. Included in cost of sales for the nine months ended September 30, 2003 was $3,249,354 provision for inventory and tooling for which there is no such amount in 2004. Without the provision, the increase in cost of sales for the first three quarters of 2004 compared to the same period in 2003 is $3,419,252, or 68%. This increase resulted largely from the 51% increase in total revenue for the nine months ended September 30, 2004 compared to the same period in 2003. Total gross margins, excluding the provision for inventory and tooling, were 23% and 31%, for the first nine months of 2004 and 2003, respectively. Gross margins from hardware sales for the first nine months of 2004 were 8% compared to 26% for 2003. Margins during the first three quarters of 2004 were negatively impacted by a large European sale of Atigo systems which was approximately break-even after initial discounts and also by a general decline in margins on other Atigo sales. Also contributing to the decrease in gross margins were Atigo and MA V systems provided free of charge for customer satisfaction purposes, warranty costs and unrecouped shipping charges totaling approximately $233,000. Absent these factors, hardware gross margins for the nine months ended September 30, 2004 were 12%. Consulting cost of sales in the first nine months of 2004 compared to 2003 increased $626,357, or 33%, which is less than the 49% increase in consulting revenue in the same period. As a result, consulting, licensing and other gross margins increased 7% and were 44% and 37% for the 2004 and 2003 periods, respectively. The increased margins in part were the result of favorable billing rates on large consulting contracts. The increase is also attributable to the $237,500 of licensing revenue recorded in 2004 related to the grant of a non-exclusive license of a patent for which there is no related cost of sales.
16
SALES AND MARKETING EXPENSES. Sales and marketing expenses for the nine months ended September 30, 2004 were $9,449,880, an increase of $3,250,189, or 52%, compared to the corresponding period in 2003. In the U.S. operations, sales and marketing expenses relating to salaries, commissions, benefits and related recruiting expenses for the nine months ended September 30, 2004 increased approximately $719,000 compared to the same period in 2003 due primarily to a headcount increase in the sales force and commissions on increased sales. Additionally, costs related to travel of sales and sales operations personnel in the U.S. also increased approximately $593,000 supporting the Companys increase in sales activity. In June 2004, the Company hosted the International Conference for Wearable Computing (ICWC) in Washington D.C. and an Asian Tech Forum. As a result, conference expenses increased approximately $269,000 for which there were no similar events in the same period in 2003. The U.S. operations also increased general marketing efforts by approximately $330,000 relating to consultants, meetings and promotional items and increased general brand marketing by approximately $195,000, consisting primarily of the sponsorship of the Alex Job Porsche Racing Team. Sales and marketing expenses also increased approximately $784,000 due to the start-up of Xybernaut China in 2004. In addition, sales and marketing expenses related to the Companys operations in Japan increased $162,000 due to an increase in headcount. Salaries and commissions increased $112,000 in the Companys operations in Germany due to increased sales and sales activity.
GENERAL AND ADMINISTRATIVE EXPENSES. General and administrative expenses for the nine months ended September 30, 2004 were $3,205,126, an increase of $181,909, or 6%, compared to the same period in 2003. Included in this increase was a $100,000 reserve recorded against accounts receivable in the third quarter of 2004. Additionally, legal expenses of $114,447 were incurred related to a lawsuit that resulted in the grant of a non-exclusive license of one of the Companys Dual-Use Computing Device patents.
RESEARCH AND DEVELOPMENT EXPENSES. The Companys research and development expenses consist primarily of personnel costs, the purchase of test equipment and payments to consultants and other third-parties which provide research and development services for mobile and wearable computing technologies. Research and development expenses for the nine months ended September 30, 2004 were $2,742,298, an increase of $33,450, or 1%, compared to the corresponding period in 2003.
INTEREST AND OTHER INCOME / EXPENSE, NET. Net interest and other income for the nine months ended September 30, 2004 was $86,828 compared to net interest and other expense of $361,552 for the same period in 2003. This increase is due to a $393,594 non-cash amortization of a note discount included in net interest and other expense for the nine months ended September 30, 2003 for which there is no such amount in 2004.
MINORITY INTEREST. Minority interest for the nine months ended September 30, 2004 was $257,868, which represents Softbank Strategics share of the losses in Xybernaut China. This joint venture was formed in 2004.
NET LOSS. As a result of the factors described above, the net loss for the nine months ended September 30, 2004 was $12,497,573, a decrease of $812,010 or 6%, compared to the nine months ended September 30, 2003.
OTHER OPERATING ACTIVITIES
For the nine months ended September 30, 2004, the Companys operating activities used cash of $12,062,630 as a result of its net loss of $12,497,573 and working capital requirements of $291,380, offset by an increase in non-cash expenses of $726,323. The Companys investing activities used cash of $366,078 through property and patent acquisitions/capitalization which were offset by a reduction in restricted cash balances. These operating activities were primarily funded through the Companys financing activities which provided cash of $8,568,474 through the private placement of common stock, exercise of warrants and stock options. As a result, the Companys cash balance decreased to $6,007,537 at September 30, 2004 from $9,524,541 at December 31, 2003.
For the nine months ended September 30, 2003, the Companys operating activities used cash of $10,111,170 as a result of its net loss of $13,309,583 and working capital requirement of $2,206,762, offset by non-cash expenses of $5,405,175. The Companys investing activities used cash of $863,279. These activities were funded through the Companys financing activities which provided cash of $21,973,880, through the private placement of common stock, exercise of warrants, stock options and borrowings. As a result, the Companys cash balance increased to $13,063,053 at September 30, 2003 from $1,967,710 at December 31, 2002.
In December 2003, the IRS filed a tax lien against the Company totaling $1,132,198. This lien covers taxes, penalties and interest that the IRS alleges the Company owes related to certain payroll tax filings during 2000. The Company believes that all such taxes were remitted to the IRS during 2000 and does not believe that such taxes are still owed to the IRS. The Company is in ongoing discussions with the IRS related to this matter and has filed returns and statements with the IRS supporting its position. The Company has received notification from the IRS that the original amount of the lien was incorrect and that the IRS has substantially reduced the amount it believes is still owed. The Company has formally requested that the lien be withdrawn. The Company believes that the probability of future payment of the taxes is remote and therefore the Company has not accrued any liability or charges. The Company believes that any related interest or penalties will not be material.
17
LIQUIDITY AND CAPITAL RESOURCES
The Company finances its operations from private sales of its common stock, borrowings, proceeds from the exercise of warrants and stock options, and sales of its products and services. The Companys financing and borrowing activities for the twelve months ended December 31, 2003 and the nine months ended September 30, 2004 are discussed below.
Common Stock
During February 2003, the Company received gross proceeds of $2,000,000 through a private placement of 6,666,667 shares of its common stock to an investor. In connection with this private placement, the Company issued to the investor callable warrants to purchase 3,333,333 shares of common stock at an exercise price of $1.25 per share.
During May 2003, the Company received gross proceeds of $3,000,000 through a private placement of 9,375,000 shares of its common stock to certain investors. In connection with this private placement, the Company issued to the investors three-year callable warrants to purchase 3,281,250 shares of common stock. These warrants had an exercise price of $0.45 if exercised in the first year, $0.90 if exercised in the second year and $1.35 if exercised in the third and final year.
During June 2003, the Company received gross proceeds of $2,000,000 through a private placement of 5,405,405 shares of its common stock to an investor. In connection with this private placement, the Company issued to the investor three-year callable warrants to purchase 4,054,054 shares of common stock. These warrants had an exercise price of $1.25 if exercised in the first year, $2.50 if exercised in the second year and $3.75 if exercised in the third and final year.
During September 2003, the Company received gross proceeds of $5,000,000 through a private placement of 6,849,315 shares of its common stock to an investor. In connection with this private placement, the Company issued to the investor three-year callable warrants to purchase 3,424,658 shares of common stock. These warrants had an exercise price of $0.91 if exercised in the first year, $1.82 if exercised in the second year and $2.73 if exercised in the third and final year.
During September 2003, the Company received gross proceeds of $2,000,000 through a private placement of 1,600,000 shares of its common stock to an investor. In connection with this private placement, the Company issued to the investor three-year callable warrants to purchase 800,000 shares of common stock. These warrants have an exercise price of $1.25 if exercised in the first year, $2.50 if exercised in the second year and $3.75 if exercised in the third and final year.
During March 2004, the Company received gross proceeds of $5,000,000 through the private placement of 3,731,343 shares of its common stock to an investor. In connection with this private placement, the Company issued to the investor three-year callable warrants to purchase 1,865,671 shares of common stock at $1.52 per share and six-month callable warrants to purchase 1,865,671 shares of common stock at $1.52 per share.
During March 2004, the Company received gross proceeds of $1,000,000 through the private placement of 662,252 shares of its common stock to an investor. In connection with this private placement, the Company issued to the investor three-year callable warrants to purchase 331,126 shares of common stock at $1.52 per share and six-month callable warrants to purchase 331,126 shares of common stock at $1.52 per share.
The Company issues warrants to purchase shares of its common stock, primarily in connection with the Companys financings and borrowings. Exclusive of the transactions discussed in Borrowings below, the Company received through the exercise of warrants net proceeds of $2,541,317 and $10,392,282 through the issuance of 2,221,797 and 23,847,427 shares of its common stock during the nine months ended September 30, 2004 and twelve months ended December 31, 2003, respectively. Concurrently with their exercise during the nine months ended September 30, 2004, the exercise price of 2,196,797 of the warrants was reduced from a weighted average of $1.52 per share to $1.15 per share. Concurrently with their exercise during the twelve months ended December 31, 2003, the exercise price of 17,116,852 warrants was reduced from a weighted average of $1.14 per share to $0.34 per share. At September 30, 2004, the Company had warrants outstanding to purchase 6,289,536 shares of its common stock at prices that range from $0.70 to $5.00 per share, with a weighted average of $2.86 per share.
Employees and consultants of the Company have exercised stock options that had been issued pursuant to the Companys various stock incentive plans. During the nine months ended September 30, 2004 and twelve months ended December 31, 2003, the Company received net proceeds of $65,717 and $109,269, respectively, and issued 132,418 and 248,996 shares of its common stock, respectively, related to these exercises.
18
Borrowings
On March 26, 2003, the Company borrowed $1,750,000 from a lender pursuant to a one-year promissory note which accrued interest at 3.5% per annum. In connection with this borrowing, the Company issued to the lender warrants to purchase 1,750,000 shares of common stock at an exercise price of $1.25 per share and warrants to purchase 2,000,000 shares of common stock at an exercise price of $0.43 per share. Based on the relative fair values of the securities issued, these warrants were assigned a value of $393,594, which amount was recorded as a note discount and amortized into interest expense over the life of the note. On May 30, 2003, the Company repaid $860,000 in principal when the lender elected to exercise the 2,000,000 warrants at $0.43 per share. Subsequent to this partial repayment, the lender provided the Company with a 10% discount on the remaining unpaid principal to induce the Company to repay the remaining principal prior to its original maturity date. The remaining principal and interest was repaid on May 30, 2003 through the: i) $89,000 discount, which was applied against the Companys Additional Paid-In Capital, ii) application of the $560,000 aggregate exercise price related to the exercise of the warrants to purchase 1,750,000 shares of common stock at $0.32 per share, a reduction from the original $1.25 per share exercise price, iii) issuance of 651,351 shares of common stock valued at $241,000, or $0.37 per share, and iv) issuance of 30,350 shares of common stock valued at $11,229, or $0.37 per share, as repayment of accrued interest. During the three and nine months ended September 30, 2003, the Company recorded interest expense of $0 and $11,229, respectively. During the three and nine months ended September 30, 2003, the Company recorded amortization of note discount of $0 and $393,594, respectively. The Company had no outstanding principal or interest related to this note at September 30, 2004 or December 31, 2003.
Purchase Commitments
Inventory. From time to time, the Company has commitments to purchase inventory, tooling and/or engineering and other services from its suppliers and manufacturers related to its current and future hardware product lines. The Companys commitments are typically highest during periods of product design and when the Company is procuring inventory related to anticipated sales. The Company expects that it will continue to enter into such commitments during 2004 and thereafter as it designs, develops and procures future mobile/wearable computer product lines.
During 2003, the Company entered into an agreement with IBM under which the Company agreed to purchase approximately $4,900,000 in MA V computing units, flat panel displays, peripherals and component parts. During 2003 the Company received all of this inventory and made payments of $4,363,458. During January 2004, the Company made the final payments required by this agreement.
At September 30, 2004, the Company had commitments to purchase approximately $3,500,000 in inventory related primarily to the Atigo product line. The Company currently expects to maintain a level of Atigo inventory on hand of approximately $2,000,000 to $5,000,000. The Company believes that this level of inventory will provide it with the ability to more rapidly deploy product to customers and also expects that it can be sold within a reasonable period after purchase. A significant portion of this future inventory will likely consist of work in process materials. The Company believes there are several benefits to purchasing work in process materials as opposed to finished goods. First, the Company typically expects to purchase only the long lead-time or hard to find components and is therefore able to defer the capital outlay needed to procure the remaining readily available materials. This strategy also reduces the risk of obsolescence since component parts are only purchased at the time they are needed in the manufacturing process, can often be used in other product lines and can be sold separately if needed. Finally, the Company maintains flexibility to customize its products based on specific customer requirements since modifications can be made at the component level prior to final assembly.
19
Other Liquidity and Capital Resources Disclosures
At September 30, 2004, the Company had accounts receivable, net of allowances, of $3,203,146, a decrease of $1,680,753, or 34%, from the December 31, 2003 balance of $4,883,899. This fluctuation is explained partly by the 12% decrease in total revenues from the quarter ended December 31, 2003 to September 30, 2004. Also included in the accounts receivable balance at December 31, 2003 is $1,554,828 associated with two fourth quarter sales for which the Company collected the balances in the first quarter of 2004. Accounts receivable at September 30, 2004 and December 31, 2003 included $178,970 and $322,152, respectively, of unbilled accounts receivable representing amounts earned and recorded under the percentage of completion method of accounting. Included in the December 31, 2003 balance was $316,391 which has been billed in the first three quarters of 2004. The Company expects to bill such amounts in their entirety upon reaching certain milestones in the contract. Included in the September 30, 2004 accounts receivable balance is $841,938 that was collected in October 2004. The Company wrote off $136,403 of previously reserved uncollectible accounts and recorded an additional $100,000 reserve against remaining accounts receivable in the third quarter of 2004.
At September 30, 2004, the Company had total accounts payable of $2,469,693, representing a decrease of $598,681, or 20%, from the December 31, 2003 balance of $3,068,374. This decrease was primarily due to the first quarter 2004 payments of liabilities resulting from large 2003 inventory purchases, including the amounts owed to IBM discussed in the Commitments section.
The deferred revenue balances at September 30, 2004 and December 31, 2003 result from billings to customers that were in excess of revenue recognized on service contracts and from warranty revenue on hardware products. Deferred revenue on service contracts is expected to be recognized as revenue as the revenue recognition criteria are met, for example as services are provided. At September 30, 2004 and December 31, 2003, $197,331 and $200,864, respectively, were recorded as deferred revenue from service contracts, of which $149,331 and $0 were classified as long-term liabilities at September 30, 2004 and December 31, 2003, respectively. Warranty revenue on hardware products is recorded as deferred revenue and recognized on a straight-line basis over the life of the warranty. At September 30, 2004 and December 31, 2003, $353,215 and $295,774, respectively, were recorded as deferred revenue from warranties, of which $170,836 and $163,754 were classified as long-term liabilities at September 30, 2004 and December 31, 2003, respectively.
The Company has recorded net losses since its inception. These losses are primarily attributable to the operating expenses incurred by the Company to design, develop, market and sell its mobile and wearable computer products and to provide general and administrative support for these operating activities. The Companys revenues and gross margins have not been sufficient to fund these operating activities. As a result, the Company has consistently reported negative cash flows from operating activities and net losses and had an accumulated deficit of $162,104,961 at September 30, 2004. The combination of the Companys operating losses and its working capital requirements has severely impacted the Companys financial position and liquidity. During 2003 and 2004, the Company funded its operating activities through its financing activities, which consist primarily of private placements of common stock, warrant and stock option exercises and borrowings.
The Companys management has taken steps that it believes are necessary to improve operations and raise additional capital, both of which are needed to meet its cash flow needs through December 31, 2004 and thereafter. During 2002 and 2003, management performed reviews of the Companys operations and implemented various cost cutting programs to reduce the Companys operating expenses to better align costs with current and expected business volume. The Companys management currently estimates that future operating expenses will approximate or exceed the level recorded during the current quarter but there can be no assurances that actual operating expenses during 2004 or later periods will not increase significantly. Future increases may also occur as a result of the Companys research and development activities, which will vary depending on the Companys wearable and mobile computer product development cycle, as well as sales, marketing and other activities. Additionally, the Companys new operations in China will increase the Companys operating expenses. The Company is also required to fund inventory procurement and other cash expenditures.
20
Management expects to fund these activities through cash on hand, gross profits and outside financings. Potential sources of additional financing include private equity offerings, warrant exercises, strategic investments and various forms of debt financing. In certain instances, concurrently with the exercise of warrants, the exercise prices have been reduced. Such reduction has resulted in the issuance of substantially more shares of common stock than would have occurred had the exercise price of the warrants not been reduced. The Company may reduce the exercise price of additional warrants in the future. If additional funds are raised through the issuance of equity securities, the percentage of ownership of current stockholders of the Company will be reduced and if additional funds are raised at current and historical prices for the Companys stock, such dilution could be significant. If additional funds are raised through borrowings, the Company will be subject to interest charges and principal repayments, will likely be required to comply with financial covenants or other restrictions, and will likely have to collateralize such borrowings with its assets, which could be taken by the lender in the event of default.
During the twelve months ended December 31, 2003 and the nine months ended September 30, 2004, the Company raised approximately $35 million, in aggregate, through sales of its common stock to institutional investors, through warrant and stock option exercises and through borrowings. If a sustained decline in the general equity markets, the price of the Companys common stock, or the U.S. or world economy were to occur, the Company could face difficulties in its ability to raise additional capital. Additionally, the Company has historically made several private placements of its common stock per year, primarily to a limited number of institutional investors who specialize in making similar types of investments. If these institutional investors were to choose to not participate in future private placements, the Company could face difficulties in its ability to raise additional capital. The Companys Certificate of Incorporation currently limits its ability to issue more than 200,000,000 shares of common stock. The Companys board of directors unanimously adopted a resolution approving a proposal to amend the Certificate of Incorporation to increase the number of authorized shares to 240,000,000. The Company has submitted to its shareholders a proposal for such an amendment, which will require approval at the Companys annual meeting currently scheduled for December 15, 2004. There can be no assurance that such an approval will be obtained. A limitation on the number of authorized shares will hinder the Companys ability to obtain additional equity financing.
The Companys management believes that the combination of cash on hand, cash flows from operations and outside additional funding from third party investors will provide sufficient liquidity to meet the Companys ongoing cash requirements. This is based on the Companys historical ability to raise funds in the form of debt and equity financings. However, there can be no assurance that the Company can or will obtain sufficient funds from operations or from additional financings on terms acceptable to the Company. If the Company is unable to obtain sufficient additional financing, it will be required to reduce spending further in order to maintain its operations at a reduced level. Management believes that it would be able to reduce spending if required, however, there can be no assurances that it can successfully do so.
Contractual Obligations and Commercial Commitments
The Companys significant contractual obligations as of September 30, 2004 are for lease payments related to a reduction in facilities classified as restructuring in 2002, operating leases (primarily for office space), inventory commitments and a five-year services agreement under which the Company agreed to pay approximately $200,000 per year for certain sales, marketing and joint business development services. The Company can terminate this services agreement with a 90 day notice.
Payments Due by Periods |
||||||||||||||||||||
Total |
Less than 1 yr |
1-3 years |
3-5 years |
Thereafter |
||||||||||||||||
Restructuring liability |
$ | 73,369 | $ | 59,759 | $ | 13,610 | $ | | $ | | ||||||||||
Operating leases |
818,507 | 589,112 | 223,211 | 6,184 | | |||||||||||||||
Services agreement |
992,000 | 202,500 | 435,500 | 234,000 | 120,000 | |||||||||||||||
Inventory commitments |
3,500,000 | 3,500,000 | | | | |||||||||||||||
$ | 5,383,876 | $ | 4,351,371 | $ | 672,321 | $ | 240,184 | $ | 120,000 | |||||||||||
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
The Company is exposed to market risk related to changes in foreign currency exchange rates and changes in interest rates. The Company does not hold investments or use derivative financial instruments for speculative or trading purposes. All of the potential changes noted below are based on sensitivity analyses performed on the Companys financial position at September 30, 2004. Actual results may differ materially.
21
FOREIGN CURRENCY EXCHANGE RISK
The majority of the Companys revenue, expense, and capital purchasing activities are transacted in U.S. dollars. However, as a result of the Companys international manufacturing, research and development, sales and marketing, inventory procurement and other activities, the Company enters into transactions denominated in other currencies, primarily the Japanese Yen, European Euro and Hong Kong Dollar or in which the U.S. Dollar equivalent is determined by the values of such currencies. The Company began operations in China in February 2004. Historically, the Company has not realized significant gains or losses in transactions denominated in, or determined by, foreign currencies. To date, the Company has not entered into foreign exchange forward or option contracts to hedge its exposure to future movements in foreign exchange rates because the Companys management believes that the potential impact of these movements does not justify the costs of entering into such contracts or the use of capital to collateralize these contracts. In the future, the Company may enter into foreign exchange forward and option contracts to hedge transactions denominated in a foreign currency if management determines that the levels of international sales or operations justify the use of such contracts. For the three and nine months ended September 30, 2004, the Companys operations in Europe comprised 16% of its total revenue and 10% of its net loss, respectively, compared to 11% of its total revenue and 6% and 7% of its net loss, respectively, in the same periods for 2003. For the three and nine months ended September 30, 2004, the Companys operations in Asia, excluding China, comprised 3% of its total revenue and 1% of its net loss, respectively, compared to 2% and 3% of its total revenue and 1% of its net loss, respectively, in the same period for 2003. For the three and nine months ended September 30, 2004, the Companys operations in China comprised 2% of its total revenue and 3% of its net loss, respectively. At September 30, 2004, the Companys assets in Europe, Asia (excluding China), and China comprised 14%, 2% and 1% of its total assets, respectively, compared to 5%, 2% and 0% of its total assets at September 30, 2003, respectively. According to published sources, the average fluctuation of the European Euro during the three and nine months ended September 30, 2004 was 1.2% and -2.5%, respectively, compared to 1.6% and 5.5% for the same period in 2003, respectively. According to published sources, the average fluctuation of the Japanese Yen during the three and nine months ended September 30, 2004 was - -1.4% and -1.7%, respectively, compared to 1.8% and 0.3% for the same period in 2003, respectively. According to published sources, the average fluctuation of the Hong Kong Dollar during the three and nine months ended September 30, 2004 was 0.0% and -0.3%, respectively. Management believes that these fluctuations did not have a material impact on the Companys results of operations or financial position for 2004 and 2003.
INTEREST RATE SENSITIVITY
From time to time, the Company is party to certain debt and credit instruments and continues to explore various financing alternatives, including debt financings. If additional funds are raised through borrowings, the Company will be subject to additional interest charges. Interest rate increases may materially increase the Companys interest expense, hinder the Companys ability to borrow additional funds or have a negative effect on the ability of the Companys customers to purchase its products. To date, the Company has not entered into interest rate forward or option contracts to hedge its exposure to future movements in interest rates because the Companys management believes that the potential impact of these movements does not justify the costs of entering into such contracts or the use of capital to collateralize these contracts. If the Companys exposure to interest rate fluctuations becomes more significant, it may enter into interest rate forward and option contracts to hedge against such fluctuations. According to published sources, the average prime interest rate during the first three quarters of fiscal year 2004 was 4.14%, compared to a 4.17% average prime interest rate during the same periods in 2003. For 2004 and 2003, the prime interest rate fluctuation from January 1 to September 30 of each year was 0.5% and -0.25%, respectively. Management believes that these fluctuations did not have a material impact on the Companys results of operations or financial position for 2004 and 2003.
ITEM 4. CONTROLS AND PROCEDURES
As of the end of the fiscal quarter ended September 30, 2004, the Company carried out an evaluation, under the supervision and with the participation of the Companys management, including the Companys Chief Executive Officer, Chief Financial Officer and President, of the effectiveness of the design and operation of the Companys disclosure controls and procedures pursuant to Exchange Act Rules. Based upon that evaluation, the Chief Executive Officer, Chief Financial Officer and President concluded that the Companys disclosure controls and procedures are effective, as of such date, to ensure that required information will be disclosed on a timely basis in its reports under the Exchange Act.
There were no significant changes in the Companys internal control over financial reporting during the last quarter that have materially affected, or are reasonably likely to materially affect, the Companys internal control over financial reporting.
22
PART II OTHER INFORMATION
ITEM 1: LEGAL PROCEEDINGS
The Company is involved in litigation with Zykronix, Inc. in the Circuit Court of Fairfax, Virginia. In that action, Zykronix filed suit against the Company seeking payment of $238,000 allegedly owed by the Company to Zykronix. The Company filed a counter suit against Zykronix seeking $1,700,000 in damages for defective products. The Virginia suit is currently pending. Zykronix has brought a separate action related to this same matter in the District Court for the City and County of Denver, Colorado. In the Colorado action, Zykronix filed suit against Edward G. Newman, the Companys Chairman and Chief Executive Officer, seeking enforcement of a personal guaranty that Mr. Newman provided to Zykronix on the behalf of the Company to guaranty liabilities allegedly owed by the Company to Zykronix. Whether or not any such amounts are owed by the Company to Zykronix is the subject of the Virginia action. In April 2004, the Denver District Court entered an Order of Judgment in favor of Zykronix and against Mr. Newman in the amount of $170,053. In May 2004, the Denver District Court entered a separate Order awarding Zykronix an additional $1,902 in attorneys fees and costs against Mr. Newman. Mr. Newman has appealed both Orders to the Colorado Court of Appeals. The Denver District Court has entered a stay of execution of the Orders pending the outcome of the appeal. Based on the pendency of the appeal, the Company, on Mr. Newmans behalf, furnished a cash supersedeas bond in the amount of $206,750 to the Denver District Court in July 2004. The cash supersedeas bond will be returned to the Company in the event of a successful appeal. The Company believes that it has substantive defenses in the Virginia action, and that Mr. Newman has grounds for appeal in the Denver action, and that no amounts will ultimately be owed to Zykronix by the Company or Mr. Newman. Mr. Newman intends vigorously to pursue his appeal in the Denver action and the Company is vigorously defending, and expects to continue to vigorously defend, the Virginia action.
The Company is involved in routine legal and administrative proceedings and claims of various types. The Company has no material pending legal or administrative proceedings, other than as discussed above or ordinary routine litigation incidental to the Companys business, to which the Company or any of its subsidiaries is a party or of which any property is the subject. While any proceeding or claim contains an element of uncertainty, management does not expect that any such proceeding or claim will have a material adverse effect on the Companys results of operations or financial position.
ITEM 2: CHANGES IN SECURITIES, USE OF PROCEEDS AND ISSUER PURCHASES OF EQUITY SECURITIES
None.
ITEM 6: EXHIBITS
EXHIBITS
31.1 | Certification Pursuant to Section 13a 14(a) of the Rules and Regulations under the Securities Exchange Act of 1934 | |||
31.2 | Certification Pursuant to Section 13a 14(a) of the Rules and Regulations under the Securities Exchange Act of 1934 | |||
31.3 | Certification Pursuant to Section 13a 14(a) of the Rules and Regulations under the Securities Exchange Act of 1934 | |||
32 | Certification Pursuant to 18 U.S.C. Section 1350 |
23
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
XYBERNAUT CORPORATION | ||
By: /s/ EDWARD G. NEWMAN | ||
Edward G. Newman Chief Executive Officer and Chairman of the Board of Directors |
||
By: /s/ THOMAS D. DAVIS Thomas D. Davis Senior Vice President and Chief Financial Officer |
||
By: /s/ STEVEN A. NEWMAN |
||
Steven A. Newman President, Chief Operating Officer and Vice Chairman of the Board of Directors |
||
Date: November 8, 2004 |
24